Attention deficit disorder with hyperactivity and Idiopathic retroperitoneal fibrosis
Idiopathic retroperitoneal fibrosis is reported only by a few people with Attention deficit disorder with hyperactivity.
The study analyzes which people have Idiopathic retroperitoneal fibrosis with Attention deficit disorder with hyperactivity. It is created by eHealthMe based on 1 person who has Idiopathic retroperitoneal fibrosis and Attention deficit disorder with hyperactivity from the Food and Drug Administration (FDA), and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who has Attention Deficit Disorder With Hyperactivity and Idiopathic Retroperitoneal Fibrosis is studied.
What is Attention deficit disorder with hyperactivity?
Attention deficit disorder with hyperactivity is found to be associated with 1,499 drugs and 1,229 conditions by eHealthMe.
What is Idiopathic retroperitoneal fibrosis?
Idiopathic retroperitoneal fibrosis (disorder that blocks the tubes (ureters) that carry urine) is found to be associated with 509 drugs and 368 conditions by eHealthMe.
Number of Idiopathic retroperitoneal fibrosis in Attention deficit disorder with hyperactivity reports submitted per year:
Gender of people who have Attention Deficit Disorder With Hyperactivity and experienced Idiopathic Retroperitoneal Fibrosis *:
- female: 0.0 %
- male: 100 %
Age of people who have Attention Deficit Disorder With Hyperactivity and experienced Idiopathic Retroperitoneal Fibrosis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 100.00%
- Depression: 1 person, 100.00%
Common symptoms for these people *:
- Weight Decreased: 1 person, 100.00%
- Weakness: 1 person, 100.00%
- Nausea And Vomiting: 1 person, 100.00%
- Nausea (feeling of having an urge to vomit): 1 person, 100.00%
- Hypogonadotropic Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries) due to a problem with the pituitary gland or hypothalamus): 1 person, 100.00%
- Hyperprolactinaemia (abnormally high levels of prolactin in the blood): 1 person, 100.00%
- Adrenal Insufficiency (condition in which the adrenal glands do not produce adequate amounts of steroids): 1 person, 100.00%
- Addison's Disease (addison's disease, a hormonal disorder disease): 1 person, 100.00%
- Abdominal Pain: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Idiopathic retroperitoneal fibrosis?Check whether Idiopathic retroperitoneal fibrosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Idiopathic retroperitoneal fibrosis:
- Idiopathic retroperitoneal fibrosis in Moderna COVID Vaccine
- Idiopathic retroperitoneal fibrosis in Pfizer BioNTech Covid Vaccine
- Idiopathic retroperitoneal fibrosis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Idiopathic retroperitoneal fibrosis:
- Idiopathic retroperitoneal fibrosis (509 drugs)
All the conditions that are associated with Idiopathic retroperitoneal fibrosis:
- Idiopathic retroperitoneal fibrosis (368 conditions)
How the study uses the data?
The study is based on Idiopathic retroperitoneal fibrosis and Attention deficit disorder with hyperactivity, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Azathioprine and Breast Cyst - 2 seconds ago
- Mircera and Clarithromycin drug interaction - 3 seconds ago
- Amlodipine and Poor Peripheral Circulation - 3 seconds ago
- Terazol 7 and Mirena drug interaction - 5 seconds ago
- Modafinil and Minoxidil drug interaction - 14 seconds ago
- Warfarin Sodium and Qualaquin drug interaction - 14 seconds ago
- Celexa and Lip Swelling - 17 seconds ago
- Levaquin and Lyme Disease - 19 seconds ago
- Krill Oil vs. Omega-3 Fatty Acid - 20 seconds ago
- Methamphetamine Hydrochloride and Cyclosporine drug interaction - 20 seconds ago